Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

Inclusion Criteria

• •1. Negative urine pregnancy test within 36 hours prior to study drug administration, if female of childbearing potential.
• •2. Females must complete the Female Enrollment Form. Those subjects of childbearing potential must agree to use one of the medically accepted methods of contraception listed on the form for a period of one month following the study. Female subjects of non-childbearing potential, defined as physiologically incapable of becoming pregnant, must meet the criteria listed on the Female Enrollment form, but are not restricted to the use of contraception following study participation.
• •3. Subjects must be able to lie on their backs for periods of 10 minutes at at time for up to a total of 60 minutes.
• •4. Children must be able to remain reasonably still for the time required for imaging.
• •5. Subjects with lymphatic dysfunction must be diagnosed with lymphedema, lipedema, or vascular malformation/anomaly that suggests a lymphatic component.
• •1. The subject has a family member with lymphatic dysfunction.
• •2. The subject is willing to have blood drawn or saliva collected for DNA analysis